Vikash Sinha

444 total citations
18 papers, 330 citations indexed

About

Vikash Sinha is a scholar working on Cellular and Molecular Neuroscience, Surgery and Pharmacology. According to data from OpenAlex, Vikash Sinha has authored 18 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 3 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in Vikash Sinha's work include Neuroscience and Neuropharmacology Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). Vikash Sinha is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). Vikash Sinha collaborates with scholars based in United States, Belgium and Sweden. Vikash Sinha's co-authors include Luis M. Vence, Abdulla K. Salahudeen, Claire Mackie, Wilhelmus Drinkenburg, Irena Loryan, Margareta Hammarlund‐Udenaes, Achiel Van Peer, Donald Heald, An Vermeulen and Luc Van Nueten and has published in prestigious journals such as Journal of Investigative Dermatology, Experimental Neurology and Pharmaceutical Research.

In The Last Decade

Vikash Sinha

16 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikash Sinha United States 9 108 82 81 61 57 18 330
Nasir Mirza United Kingdom 9 102 0.9× 69 0.8× 24 0.3× 19 0.3× 36 0.6× 17 331
Aaron Walker United States 12 104 1.0× 28 0.3× 30 0.4× 30 0.5× 117 2.1× 21 395
Erin St. Onge United States 12 160 1.5× 93 1.1× 57 0.7× 12 0.2× 77 1.4× 38 534
W. McNally United States 12 104 1.0× 54 0.7× 45 0.6× 26 0.4× 65 1.1× 16 438
Holger Fuchs Germany 15 263 2.4× 289 3.5× 374 4.6× 21 0.3× 31 0.5× 32 876
Laigao Chen United States 12 146 1.4× 77 0.9× 76 0.9× 28 0.5× 92 1.6× 22 503
Fuka Aizawa Japan 11 105 1.0× 70 0.9× 29 0.4× 11 0.2× 97 1.7× 41 305
Emily J. Gilles United States 11 86 0.8× 29 0.4× 31 0.4× 22 0.4× 176 3.1× 17 403
Kaleigh F. Roberts United States 7 85 0.8× 42 0.5× 50 0.6× 23 0.4× 214 3.8× 16 340
P Corvol France 11 207 1.9× 138 1.7× 114 1.4× 18 0.3× 25 0.4× 22 667

Countries citing papers authored by Vikash Sinha

Since Specialization
Citations

This map shows the geographic impact of Vikash Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikash Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikash Sinha more than expected).

Fields of papers citing papers by Vikash Sinha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikash Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikash Sinha. The network helps show where Vikash Sinha may publish in the future.

Co-authorship network of co-authors of Vikash Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Vikash Sinha. A scholar is included among the top collaborators of Vikash Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikash Sinha. Vikash Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sinha, Vikash, et al.. (2025). 0432 Guselkumab pharmacokinetics and immunogenicity in pediatric psoriasis: Phase 3 PROTOSTAR study. Journal of Investigative Dermatology. 145(8). S74–S74.
2.
Seyger, Marieke M.B., Dagmar Wilsmann‐Theis, Andrzej Kaszuba, et al.. (2024). Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR study. British Journal of Dermatology. 192(4). 618–628. 1 indexed citations
3.
Sinha, Vikash, Elvan Ceyhan, Livia Sura, et al.. (2023). Deep cerebral venous abnormalities in premature babies with GMH-IVH: a single-centre retrospective study. BMJ Paediatrics Open. 7(1). e001853–e001853.
4.
Sinha, Vikash, et al.. (2020). Retroperitoneal Bronchogenic Cyst: A Rare Case Study. Cureus. 12(9). e10421–e10421. 5 indexed citations
5.
Sinha, Vikash, et al.. (2019). A Rare Case of Epididymal Cyst Due to Schistosomiasis. Cureus. 11(9). e5755–e5755. 2 indexed citations
6.
Sinha, Vikash, et al.. (2019). Artifact from myomectomy/C-Section on MRI images – what does this mean for MR-guided focused ultrasound candidacy for uterine fibroids?. International Journal of Hyperthermia. 36(1). 1078–1082. 2 indexed citations
7.
Sinha, Vikash, et al.. (2018). Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats. Experimental Neurology. 313. 26–36. 15 indexed citations
8.
9.
Streffer, Johannes, Anne Börjesson‐Hanson, Bianca Van Broeck, et al.. (2016). O1‐10‐05: Pharmacodynamics of the Oral Bace Inhibitor JNJ‐54861911 in Early Alzheimer's Disease. Alzheimer s & Dementia. 12(7S_Part_4). 4 indexed citations
10.
Timmers, Maarten, Bianca Van Broeck, Steven Ramael, et al.. (2016). Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ‐54861911, a potent oral BACE inhibitor. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2(3). 202–212. 48 indexed citations
11.
Anghelescu, Ion, Iva Kezic, Vikash Sinha, et al.. (2015). Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies. Journal of Psychopharmacology. 29(4). 414–425. 42 indexed citations
12.
Ahnaou, A., Peter de Boer, Hilde Lavreysen, et al.. (2015). Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men. Neuropharmacology. 103. 290–305. 12 indexed citations
13.
Patel, Achint, Abhimanyu Mahajan, Alexandre Benjo, et al.. (2015). A National Perspective of Do-Not-Resuscitate Order Utilization Predictors in Intracerebral Hemorrhage. The Neurohospitalist. 6(1). 7–10. 11 indexed citations
14.
Loryan, Irena, Vikash Sinha, Claire Mackie, et al.. (2014). Mechanistic Understanding of Brain Drug Disposition to Optimize the Selection of Potential Neurotherapeutics in Drug Discovery. Pharmaceutical Research. 31(8). 2203–2219. 52 indexed citations
15.
Loryan, Irena, Vikash Sinha, Claire Mackie, et al.. (2014). Molecular Properties Determining Unbound Intracellular and Extracellular Brain Exposure of CNS Drug Candidates. Molecular Pharmaceutics. 12(2). 520–532. 53 indexed citations
16.
17.
Bergh, An Van den, Vikash Sinha, Ron Gilissen, et al.. (2011). Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data. Clinical Pharmacokinetics. 50(8). 505–517. 23 indexed citations
18.
Sinha, Vikash, et al.. (1998). Endoscopic intranasal dacryocystorhinostomy. Indian Journal of Otolaryngology and Head & Neck Surgery. 50(1). 84–85. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nasir Mirza Breakdown of academic impact, for papers by Aaron Walker Breakdown of academic impact, for papers by Erin St. Onge Breakdown of academic impact, for papers by W. McNally Breakdown of academic impact, for papers by Holger Fuchs Breakdown of academic impact, for papers by Laigao Chen Breakdown of academic impact, for papers by Fuka Aizawa Breakdown of academic impact, for papers by Emily J. Gilles Breakdown of academic impact, for papers by Kaleigh F. Roberts Breakdown of academic impact, for papers by P Corvol
Rankless by CCL
2026